- Home
- HLX vs KOD Comparison
HLX vs KOD Comparison
Compare HLX & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HLX | KOD |
|---|---|---|
| Founded | 1979 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.8M | 795.5M |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HLX | KOD |
|---|---|---|
| Price | $7.25 | $24.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $10.50 | ★ $22.29 |
| AVG Volume (30 Days) | ★ 1.4M | 728.8K |
| Earning Date | 10-22-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 497.36 | N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $1,312,445,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.96 | N/A |
| P/E Ratio | $25.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.52 | $1.92 |
| 52 Week High | $10.21 | $26.21 |
Technical Indicators
Market Signals| Indicator | HLX | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 59.27 | 62.57 |
| Support Level | $7.24 | $21.24 |
| Resistance Level | $7.51 | $26.21 |
| Average True Range (ATR) | 0.28 | 1.79 |
| MACD | 0.07 | 0.18 |
| Stochastic Oscillator | 71.86 | 73.71 |
Price Performance
Historical ComparisonAbout HLX Helix Energy Solutions Group Inc.
Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.